Nacre Capital

Nacre Capital is a global venture builder that creates, builds and grows start-ups founded on deep technology and hard science. The firm works side-by-side with its ventures from idea to market leadership, supplying operational, financial, business development and legal support across the whole company journey, and recruiting entrepreneurs and talent to build teams. Its areas of work span biotechnology, health technology, agriculture technology, aquaculture technology, security technology and cultural technology, with a strong emphasis on core research and development.

The approach is intended to build durable competitive advantage: a research base of more than 200 academic papers, upwards of 500 research collaborations and over 140 granted patents underpin the firm's portfolio work. Nacre Capital remains actively involved in scaling ventures globally, with a stated focus on technologies that have a significant impact on people's lives.

Two in-house portfolio companies have reached exit. CyberMDX, a healthcare and security venture, was acquired by Forescout in 2022. Glassbox was acquired by Alicorn Venture Partners in 2024.